Log In
BCIQ
Print this Print this
 

ATH-91385

  Manage Alerts
Collapse Summary General Information
Company Athersys Inc.
DescriptionSerotonin (5-HT2C) receptor agonist
Molecular Target Serotonin (5-HT2C) receptor
Mechanism of ActionSerotonin (5-HT2C) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today